Xuhui District Centre for Disease Control and Prevention, Shanghai, China.
School of Public Health, University of South China, Hunan Province, China.
Clin Microbiol Infect. 2019 Jul;25(7):872-877. doi: 10.1016/j.cmi.2018.11.013. Epub 2018 Nov 23.
Although administration of a second dose of varicella vaccine (2-dose VarV) to individuals who have previously received one-dose VarV has been recommended as a post-exposure prophylaxis (PEP) strategy for outbreak control, the effectiveness of this strategy remains unclear. We evaluated the vaccine effectiveness (VE) of 2-dose VarV as PEP among students involved in 129 varicella outbreaks in Shanghai, China from 2013 to 2016.
Students who had received one-dose VarV more than 5 years prior to varicella exposure were eligible to receive 2-dose VarV as PEP. We evaluated the VE using the following formula: VE = (1 - hazard ratio (HR)) × 100%.
A total of 6762 students were eligible for 2-dose VarV, of whom 58.6% accepted PEP after varicella exposure. The adjusted VE of 2-dose VarV as PEP was 77% (95% confidence interval 64-85%). In addition, the adjusted VE of 2-dose VarV as PEP in affected classrooms with high vaccine uptake was higher than that in classrooms with lower vaccine uptake (87% vs. 69%). The adjusted VE was also higher in students who received 2-dose VarV within 3 days of exposure than those who received it more than 3 days post exposure (77% vs. 64%).
These Results suggest that administration of 2-dose VarV as PEP is an appropriate intervention for outbreak control in countries where two-dose VarV has not been adopted.
尽管向曾接种过一剂水痘疫苗(2 剂 VarV)的个体接种第 2 剂 VarV 已被推荐作为暴发控制的暴露后预防(PEP)策略,但该策略的有效性仍不清楚。我们评估了 2 剂 VarV 作为 PEP 在上海的 129 起水痘暴发中对学生的疫苗效力(VE),这些暴发发生于 2013 年至 2016 年。
曾在水痘暴露前 5 年以上接种过一剂 VarV 的学生有资格接种 2 剂 VarV 作为 PEP。我们使用以下公式评估 VE:VE =(1 - 风险比(HR))×100%。
共有 6762 名学生有资格接种 2 剂 VarV,其中 58.6%在水痘暴露后接受了 PEP。2 剂 VarV 作为 PEP 的调整 VE 为 77%(95%置信区间 64-85%)。此外,在疫苗接种率较高的受影响教室中,2 剂 VarV 作为 PEP 的调整 VE 高于疫苗接种率较低的教室(87%比 69%)。在暴露后 3 天内接种 2 剂 VarV 的学生中,调整后的 VE 也高于暴露后超过 3 天接种 2 剂 VarV 的学生(77%比 64%)。
这些结果表明,在尚未采用 2 剂 VarV 的国家,接种 2 剂 VarV 作为 PEP 是控制暴发的一种适当干预措施。